Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Letendre

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
AIDS and Behavior|March 4, 2015
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV DiseasePariya L Fazeli, Maria J Marquine, Catherine Dufour, et al.
AIDS (London, England)|August 19, 2016
HIV-associated neurocognitive disorder is associated with HIV-1 dual infectionGabriel A Wagner, Antoine Chaillon, Siqi Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 29, 2022
Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIVOluwakemi K Okwuegbuna, Harpreet Kaur, Iudicello Jennifer, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|November 8, 2019
Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational StudyElizabeth C Pasipanodya, Jessica L Montoya, Laura M Campbell, et al.
AIDS and Behavior|December 16, 2014
Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorderDavid J Moore, Amelia Poquette, Kaitlin B Casaletto, et al.
AIDS (London, England)|December 4, 2008
Low atazanavir concentrations in cerebrospinal fluidBrookie M Best, Scott L Letendre, Eileen Brigid, et al.
Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.
Journal of Neurovirology|March 24, 2009
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individualsAssawin Gongvatana, Brian C Schweinsburg, Michael J Taylor, et al.
Neurology|February 15, 2012
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorderJ A McCutchan, J A Marquie-Beck, C A Fitzsimons, et al.
Virology|September 19, 2009
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performanceGeorge K Hightower, Scott L Letendre, Mariana Cherner, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
AIDS and Behavior|March 4, 2015
Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV DiseasePariya L Fazeli, Maria J Marquine, Catherine Dufour, et al.
AIDS (London, England)|August 19, 2016
HIV-associated neurocognitive disorder is associated with HIV-1 dual infectionGabriel A Wagner, Antoine Chaillon, Siqi Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 29, 2022
Anemia and Erythrocyte Indices Are Associated With Neurocognitive Performance Across Multiple Ability Domains in Adults With HIVOluwakemi K Okwuegbuna, Harpreet Kaur, Iudicello Jennifer, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|November 8, 2019
Metabolic Risk Factors as Differential Predictors of Profiles of Neurocognitive Impairment Among Older HIV+ and HIV- Adults: An Observational StudyElizabeth C Pasipanodya, Jessica L Montoya, Laura M Campbell, et al.
AIDS and Behavior|December 16, 2014
Individualized texting for adherence building (iTAB): improving antiretroviral dose timing among HIV-infected persons with co-occurring bipolar disorderDavid J Moore, Amelia Poquette, Kaitlin B Casaletto, et al.
AIDS (London, England)|December 4, 2008
Low atazanavir concentrations in cerebrospinal fluidBrookie M Best, Scott L Letendre, Eileen Brigid, et al.
Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.
Journal of Neurovirology|March 24, 2009
White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individualsAssawin Gongvatana, Brian C Schweinsburg, Michael J Taylor, et al.
Neurology|February 15, 2012
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorderJ A McCutchan, J A Marquie-Beck, C A Fitzsimons, et al.
Virology|September 19, 2009
Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performanceGeorge K Hightower, Scott L Letendre, Mariana Cherner, et al.
Pageof 25